Please review the following URL and make sure that it is spelled correctly. This is not a list of all drugs or health problems that interact with hydroxychloroquine. Negative ana with plaquenil Corneal pics chloroquine side effects Retinal thinning in plaquenil toxicity oct Plaquenil 200 mg brch Annual screening may be commenced before 5 years of treatment if additional risk factors for retinal toxicity exist, such as concomitant tamoxifen therapy, impaired renal function eGFR less than 60 mL/minute/1.73 m 2 or high-dose therapy greater than 5 mg/kg/day of hydroxychloroquine sulfate. Hydroxychloroquine sulfate tablets are indicated for the treatment of uncomplicated malaria due to P. falciparum, P. malariae, P. ovale, and P. vivax. Hydroxychloroquine sulfate tablets are indicated for the prophylaxis of malaria in geographic areas where chloroquine resistance is not reported. Limitations of Use in Malaria Hydroxychloroquine sulfate salt 200 mg is equivalent to hydroxychloroquine base 155 mg. additional monitoring, and/or selection of alternative therapy. Consult. You must check to make sure that it is safe for you to take hydroxychloroquine with all of your drugs and health problems. Tell your doctor and pharmacist about all of your drugs (prescription or OTC, natural products, vitamins) and health problems. Hydroxychloroquine sulfate monitoring Hydroxychloroquine/QT Prolonging Agents Interactions, Hydroxychloroquine Tablets - FDA prescribing information. Plaquenil and bradycardiaChloroquine kinaseHow frequent is vision loss from plaquenil Hydroxychloroquine Sulfate Drug Information from Includes Hydroxychloroquine Sulfate side effects, interactions and indications. Patient monitoring The following may be especially important in patient monitoring other tests may be warranted in some patients. Hydroxychloroquine Sulfate Drug Information, Professional. Hydroxychloroquine Professional Patient Advice -. Eye screening for patients taking hydroxychloroquine Plaquenil. Pharmacokinetics Following a single 200 mg oral dose of hydroxychloroquine sulfate tablets to healthy males, the mean peak blood concentration of hydroxychloroquine was 129.6 ng/mL, reached In 3.26 hours with a half-life of 537 hours 22.4 days. For individuals with significant risk factors daily dose of hydroxychloroquine sulfate greater than 5.0 mg/kg base of actual body weight, subnormal glomerular filtration, use of tamoxifen citrate or concurrent macular disease monitoring should include annual examinations which include BCVA, VF and SD-OCT. Hydroxychloroquine Plaquenil is considered a disease-modifying anti-rheumatic drug DMARD. It can decrease the pain and swelling of arthritis. It may prevent joint damage and reduce the risk of long-term disability. Hydroxychloroquine is in a class of medications that was first used to prevent and treat malaria.